Showing results (251-260 of 1,289) with videos related to
Sort By:
Pageof 129
Journal of Comparative Effectiveness Research|August 12, 2024
A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacyJeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, et al.Journal of Comparative Effectiveness Research|August 12, 2024
An international observational study assessing conservative management in hemorrhoidal disease: results of CHORALIS (aCute HemORrhoidal disease evALuation International Study)Philippe Godeberge, Zoltan Csiki, Mykhailo Zakharash, et al.Journal of Comparative Effectiveness Research|August 12, 2024
The maze of real-world evidence frameworks: from a desert to a jungle! An environmental scan and comparison across regulatory and health technology assessment agenciesGrammati Sarri, Luis G HernandezJournal of Comparative Effectiveness Research|July 5, 2024
RWE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 16Alejandra Castanon, Antonia Tsvetanova, Sreeram V RamagopalanJournal of Comparative Effectiveness Research|July 24, 2024
COVID-19 clinical trials: who is likely to participate and why?Kimberly A Fisher, Mara M Epstein, Ngoc Nguyen, et al.Journal of Comparative Effectiveness Research|June 13, 2024
Six-minute walk test as clinical end point in cardiomyopathy clinical trials, including ATTR-CM: a systematic literature reviewJose Nativi-Nicolau, Ali Yilmaz, Noel Dasgupta, et al.Journal of Comparative Effectiveness Research|September 5, 2023
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in CanadaHamza Alshannaq, John J Isitt, Richard F Pollock, et al.Journal of Comparative Effectiveness Research|September 15, 2023
Cost-effectiveness of weekly gastro-resistant risedronate 35 mg, compared with weekly alendronate 70 mg tablets, in the treatment of postmenopausal osteoporosis in SpainEnrique Casado, José Rosas, Carlos Rubio-Terrés, et al.Journal of Comparative Effectiveness Research|August 29, 2023
Overall survival in the UK in mycosis fungoides or Sézary syndrome cutaneous T-cell lymphoma: comparative effectiveness of mogamulizumab versus current standard of careNeil Hawkins, Noemi Muszbek, Rachel Evans, et al.Journal of Comparative Effectiveness Research|September 1, 2023
The cost-effectiveness of pegcetacoplan in complement treatment-naïve adults with paroxysmal nocturnal hemoglobinuria in the USAJesse Fishman, Koo Wilson, Aleksandra Drzewiecka, et al.Pageof 129